Governance NovoCure Limited

NVCR

JE00BYSS4X48

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2026-02-13 pm EST			5-day change	1st Jan Change
10.99 ^USD	-12.29%		+8.38%	-15.00%

Feb. 12	FDA approves first-of-its-kind device to treat pancreatic cancer	RE
Feb. 12	Sector Update: Health Care Stocks Rise Late Afternoon	MT

Executive Committee: NovoCure Limited

Manager

Positions heldSince

Frank Leonard

46 year

Chief Executive Officer

2025-11-30

Christoph Brackmann

52 year

Director of Finance/CFO

2024-12-31

Barak Ben Arye

50 year

General Counsel

2022-03-31

Moshe Giladi

Chief Tech/Sci/R&D Officer

2023-01-16

Michael Puri

57 year

Human Resources Officer

2023-08-31

Nicolas Leupin

52 year

Chief Tech/Sci/R&D Officer

2024-01-03

Composition of the Board of Directors: NovoCure Limited

Director

CommitteesSince

Bill Doyle

63 year

Compensation Committee	2021-12-31
Governance Committee Chair	2021-12-31
Nominating Committee Chair	2021-12-31

Tony Vernon

69 year

Compensation Committee Chair	2019-05-31
HR Committee Chair
Governance Committee	2019-05-31
Nominating Committee	2019-05-31

Timothy Scannell

61 year

Governance Committee Chair
Nominating Committee Chair
Audit Committee
Compensation Committee	2024-10-15

Jeryl Hilleman

68 year

Audit Committee Chair	2019-03-31
Governance Committee	2021-06-09
Nominating Committee	2021-06-09

David Hung

69 year

Governance Committee
Nominating Committee

Kin Yip Leung

65 year

Governance Committee
Nominating Committee

Martin Madden

66 year

Audit Committee	2017-05-09
Compensation Committee

Allyson Ocean

55 year

Governance Committee
Nominating Committee

Kristin Stafford

45 year

Compensation Committee

2023-03-27

Asaf Danziger

58 year

Director/Board Member

2011-12-31

Latest Appointments: NovoCure Limited

Dec. 01	Novocure Limited Announces CEO Changes	CI
Dec. 01	Novocure appoints company president Frank Leonard as chief executive officer	RE
Dec. 01	NovoCure Names Frank Leonard as Chief Executive	MT
24-11-21	Novocure FDA Approves Novocure?S Innovative HFE Transducer Arrays for Use with Optune Gio® for Glioblastoma	CI
24-10-30	NovoCure Names New Chief Financial Officer	MT
24-10-30	NovoCure Limited Appoints Christoph Brackmann as Senior Financial Advisor	CI
24-10-30	NovoCure Limited Announces CFO Appointment	CI

More news

Former Officers and Directors: NovoCure Limited

Insider

Positions held

SinceUntil

Ashley Cordova

Director/Board Member	2025-06-03	2025-11-23
Chief Executive Officer	2024-12-31	2025-11-29
Director of Finance/CFO	2020-08-31	2024-12-31
Investor Relations Contact	2015-02-28	-
Public Communications Contact	2015-02-28	-
Corporate Officer/Principal	2014-05-31	2015-02-28

Wilhelmus Groenhuysen

Chief Operating Officer	2020-08-31	2024-09-30
Director of Finance/CFO	2012-01-04	2020-08-31

Pritesh Shah

Corporate Officer/Principal	2012-10-31	2023-12-31
Sales & Marketing	2012-10-31	-

Gabrielle Fernandes

Investor Relations Contact	-	2021-02-28
Corporate Officer/Principal	2021-02-28	2023-10-31

Ely Benaim

Chief Tech/Sci/R&D Officer

2019-03-31

2023-01-16

Sherilyn McCoy

Director/Board Member	2018-05-30	2022-06-07
Independent Dir/Board Member	2018-05-30	2022-06-07

Todd Longsworth

General Counsel

2012-03-31

2022-03-30

Ingrid Goldberg

Investor Relations Contact

2021-06-30

Charles G. Phillips

Director/Board Member	2011-12-31	2020-04-19
Independent Dir/Board Member	2011-12-31	2020-04-19

Bill Burkoth

Director/Board Member	2008-12-31	2019-05-21
Independent Dir/Board Member	2008-12-31	2019-05-21

Eilon D. Kirson

Chief Tech/Sci/R&D Officer

2001-12-31

2019-04-30

Louis Lavigne

Director/Board Member	2012-12-31	2018-10-23
Independent Dir/Board Member	2012-12-31	2018-10-23

Yoram Palti

Director/Board Member	2001-12-31	-
Chief Tech/Sci/R&D Officer	1999-12-31	-
Founder	1999-12-31	2018-10-23

Gert Lennart Perlhagen

Director/Board Member	2002-12-31	2018-05-30
Independent Dir/Board Member	2002-12-31	2018-05-30

Bob Mylod

Director/Board Member	2011-12-31	2017-05-09
Independent Dir/Board Member	-	2017-05-09

Peter Melnyk

Corporate Officer/Principal

2011-12-13

2017-03-14

Tim Langloss

Director/Board Member	-	2016-05-03
Independent Dir/Board Member	2008-12-31	2016-05-03

William Bruke

Human Resources Officer

2013-12-31

James Lenehan

Director/Board Member

2013-01-07

Angela M. Davies

Corporate Officer/Principal

2011-12-13

Laura Benson

Chief Tech/Sci/R&D Officer

2011-12-13

Michael Ambrogi

Chief Operating Officer	2009-12-31	2020-08-31
Corporate Officer/Principal	2020-08-31	-

Jaclyn Stahl

Public Communications Contact

Leigh Labrie

Public Communications Contact

Piet Hinoul

Chief Tech/Sci/R&D Officer

Age distribution of managers

Parity Men Women

Male	16
Female	3

Of which Executive Committee

Male	6
Female	0

Of which Directors

Male	8
Female	2

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

NovoCure Limited is a global oncology company. The Company is engaged in the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua for the treatment of solid tumor cancers. Its commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, malignant pleural mesothelioma and pleural mesothelioma. It is conducting pivotal studies evaluating the use of TTFields in the treatment of ovarian cancer, brain metastases from non-small cell lung cancer (NSCLC) (brain metastases) and pancreatic cancer. Its key priorities are to drive commercial adoption of Optune, its commercial TTFields device. It also has a license to market Optune in China, Hong Kong, Macau and Taiwan. It has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer and ovarian cancer.

Employees

1,488

Sector

Medical Equipment, Supplies & Distribution

Calendar

Feb. 25 - Q4 2025 Earnings Release

More about the company